BHI Team Members

Stephanie E. Toney is a highly accomplished Global Market Access & Health Economics executive with over two decades of experience delivering revenue and market share growth for leading medical device and diagnostics companies. Currently serving as an Independent Consultant through her firm Wide Horizons Consulting, LLC, she specializes in market access and reimbursement strategies for healthcare innovation companies. Stephanie holds a Master of Business Administration with a concentration in Marketing from the University of Wisconsin-Madison (2004) and a Bachelor of Science in Management with a concentration in Finance from Tulane University (1995). She was also a Consortium for Graduate Study in Management Fellow at the University of Wisconsin-Madison. Her expertise spans global market access, medical device and diagnostics expertise, global reimbursement and payment policy, coverage and coding strategies, and health economics outcomes research. She has established herself as a subject-matter expert consistently called upon by sales, marketing, senior leadership, and advocate groups for her deep knowledge of clinical matters, policies, procedures, and regulations.

Kwame Ulmer is a distinguished medical technology executive and regulatory strategist with over 20 years of experience navigating the complex intersection of innovation, regulation, and commercialization in healthcare. As Managing Partner of MedTech Impact Partners, a specialized regulatory strategy consulting firm, Kwame has established himself as a trusted advisor to medical device companies seeking to successfully navigate FDA requirements and bring life-changing technologies to market.

Dr. Stephen D. Wolpe is a distinguished biotechnology executive and scientific pioneer with over 30 years of experience in therapeutic and diagnostic development, particularly renowned for his groundbreaking discoveries in immunotherapy and inflammatory mediators. As a discoverer of the chemokine superfamily of inflammatory mediators, Dr. Wolpe has fundamentally shaped our understanding of immune system regulation and hematopoiesis.

Anna Zornosa is a seasoned healthcare entrepreneur and executive with deep expertise in building, scaling, and transforming life sciences companies at the intersection of digital technologies and health. As both a successful CEO and strategic advisor, she brings a unique combination of operational excellence, fundraising acumen, and extensive industry networks to help early-stage companies navigate the complex path from innovation to market success.